Head-to-head · WeighScore
Mevo Health vs Recovery Delivered
By GLP-1 ScorecardUpdated
Score comparison
Recovery Delivered has the higher recorded score — 60.7/100 to 60.2/100, but only just.
Recovery Delivered grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Recovery Delivered is a US telehealth service (Tara Healthcare LLC) that offers compounded GLP-1 weight-loss medication alongside its addiction-recovery care. Mevo Health is close behind and may still be the better fit — see the factor split below.
Before you choose
Before comparing the headline prices, the Mevo Health review and the Recovery Delivered review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, Mevo Health vs SkyRx and No BS RX vs Recovery Delivered compare each of them with another graded program, and the list of alternatives to Mevo Health ranks the programs closest to Mevo Health on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the HumeCare+ review covers one graded close to these two, at 58.6/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Mevo Health | Recovery Delivered |
|---|---|---|
| WeighScore | 60.2/100 | 60.7/100 |
| Grade | C | C |
| Site position | #356 | #345 |
| Semaglutide | $199/mo (all doses, compounded) | $199/mo (starting dose, compounded) |
| Tirzepatide | $259/mo (all doses, compounded) | $219/mo (2.5 mg dose, compounded) |
| Coverage | Coverage not published | 32 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- LegitScript verification badge on multiple pages
- Publishes the FDA compounded-medication disclaimer
- Four named board-certified physicians disclosed (Wasef, Suppa, Sakla, Chikando)
- Both semaglutide and tirzepatide in injection and oral-tablet forms — rare in DTC
- Public entry-level pricing surfaced
What to consider
- States served not listed on any public page
- Pharmacy partners not named (only '503A U.S. compounding pharmacies' with unlabeled logos)
- No formal Medical Director role disclosed
- Only 'as low as' entry pricing shown — no per-dose itemization
- No SOC 2 certification claimed
Strengths
- Low entry price: compounded semaglutide from $199.99/mo, tirzepatide from $219/mo
- Video visit with a provider and home delivery included in the price
- Offers both injectable and oral compounded GLP-1 options
What to consider
- Compounding pharmacy is not publicly named
- Not available in 19 states (including CA, IL, TN, GA, MI)
- Higher semaglutide doses cost up to $299.99/mo
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.